October 19, 2009 – PLC Systems Inc. today said its RenalGuard System will be utilized as part of a live case transmission from the Clinica Mediterranea, Naples, Italy, to the 30th Congresso Nazionale della Societa' Italiana di Cardiologia Invasiva (GISE), Oct. 20-23, in Bologna, Italy.
October 16, 2009 – Correlagen recently expanded its CardioGeneScan test, the first comprehensive genetic test for the diagnosis of familial cardiac disease.
October 16, 2009 – AstraZeneca yesterday said the U.S. Food and Drug Administration cleared CRESTOR (rosuvastatin calcium) for use in pediatric patients ages 10-17 with heterozygous familial hypercholesterolemia (HeFH) when diet therapy fails to reduce elevated cholesterol.
October 16, 2009 – BIOTRONIK yesterday said it recently received the Industry’s first European CE Mark approval so BIOTRONIK Home Monitoring can replace in-hospital device follow-up visits.
October 16, 2009 – The Clinical Center of Serbia, Institute for Cardiovascular Diseases today said it treated its first patient with a revolutionary cell-based therapy for heart failure.
October 16, 2009 - At the 95th annual RSNA meeting, Nov. 29-Dec 4, in Chicago, Agfa Healthcare will show how IMPAX Cardiovascular is designed to support heart and vascular diagnostics and documentation.
October 15, 2009 – Kardia Health Systems, today announced the availability of ConnectedCare, the first complete, online, fee-per-study cardiovascular information system (CVIS).
October 15, 2009 – A study conducted by the University of Rochester Medical Center (URMC) demonstrates that, for certain patient populations, an experimental device that lowers blood pressure may be a cost effective treatment. The implantable device, called Rheos, is in advanced stages of testing for individuals with drug-resistant hypertension.
October 15, 2009 – Biosense Webster Inc. said today the U.S. Food and Drug Administration cleared the CARTO 3 System, an advanced 3D imaging technology for use by electrophysiologists in treating cardiac arrhythmias.
